Total Liabilities Summary of Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited's latest annual total liabilities in 2023 was 54.29 Billion ZAR , up 13.0% from previous year.
Aspen Pharmacare Holdings Limited's latest quarterly total liabilities in 2023 Q4 was 54.29 Billion ZAR , down 0.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported annual total liabilities of 48.04 Billion ZAR in 2022, up 18.83% from previous year.
Aspen Pharmacare Holdings Limited reported annual total liabilities of 40.43 Billion ZAR in 2021, down -8.23% from previous year.
Aspen Pharmacare Holdings Limited reported quarterly total liabilities of 53.69 Billion ZAR for 2023 Q1, up 11.75% from previous quarter.
Aspen Pharmacare Holdings Limited reported quarterly total liabilities of 54.29 Billion ZAR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Total Liabilities of Aspen Pharmacare Holdings Limited (2023 - 2002)

Year	Total Liabilities	Total Liabilities Growth
2023	54.29 Billion ZAR	13.0%
2022	48.04 Billion ZAR	18.83%
2021	40.43 Billion ZAR	-8.23%
2020	44.05 Billion ZAR	-31.11%
2019	63.95 Billion ZAR	-6.1%
2018	68.1 Billion ZAR	-17.69%
2017	82.74 Billion ZAR	13.03%
2016	73.2 Billion ZAR	18.45%
2015	61.8 Billion ZAR	13.9%
2014	54.25 Billion ZAR	1.09%
2013	53.67 Billion ZAR	137.24%
2012	22.62 Billion ZAR	57.98%
2011	14.32 Billion ZAR	6.0%
2010	13.51 Billion ZAR	51.55%
2009	8.91 Billion ZAR	7.94%
2008	8.25 Billion ZAR	9.68%
2007	7.52 Billion ZAR	46.42%
2006	5.14 Billion ZAR	102.17%
2005	2.54 Billion ZAR	25.33%
2004	2.02 Billion ZAR	94.55%
2003	1.04 Billion ZAR	17.64%
2002	886.73 Million ZAR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q2	53.69 Billion ZAR	0.0%
2023 Q1	53.69 Billion ZAR	11.75%
2023 Q4	54.29 Billion ZAR	0.0%
2022 Q2	45.36 Billion ZAR	0.0%
2022 Q1	45.36 Billion ZAR	12.2%
2022 FY	48.04 Billion ZAR	18.83%
2022 Q3	48.04 Billion ZAR	5.91%
2022 Q4	48.04 Billion ZAR	0.0%
2021 Q3	40.43 Billion ZAR	-10.9%
2021 Q4	40.43 Billion ZAR	0.0%
2021 FY	40.43 Billion ZAR	-8.23%
2021 Q2	45.38 Billion ZAR	0.0%
2021 Q1	45.38 Billion ZAR	3.01%
2020 Q4	44.05 Billion ZAR	0.0%
2020 Q1	57.85 Billion ZAR	-9.53%
2020 Q2	57.85 Billion ZAR	0.0%
2020 Q3	44.05 Billion ZAR	-23.85%
2020 FY	44.05 Billion ZAR	-31.11%
2019 Q1	61.74 Billion ZAR	-9.33%
2019 Q2	61.74 Billion ZAR	0.0%
2019 FY	63.95 Billion ZAR	-6.1%
2019 Q3	63.95 Billion ZAR	3.57%
2019 Q4	63.95 Billion ZAR	0.0%
2018 Q2	82.53 Billion ZAR	0.0%
2018 FY	68.1 Billion ZAR	-17.69%
2018 Q4	68.1 Billion ZAR	0.0%
2018 Q3	68.1 Billion ZAR	-17.48%
2018 Q1	82.53 Billion ZAR	-0.25%
2017 Q2	78.2 Billion ZAR	0.0%
2017 Q3	82.73 Billion ZAR	5.8%
2017 Q4	82.74 Billion ZAR	0.01%
2017 FY	82.74 Billion ZAR	13.03%
2017 Q1	78.2 Billion ZAR	6.83%
2016 FY	73.2 Billion ZAR	18.45%
2016 Q3	73.2 Billion ZAR	6.86%
2016 Q4	73.2 Billion ZAR	-0.0%
2016 Q2	68.5 Billion ZAR	0.0%
2016 Q1	68.5 Billion ZAR	10.84%
2015 FY	61.8 Billion ZAR	13.9%
2015 Q1	62.11 Billion ZAR	14.49%
2015 Q2	62.11 Billion ZAR	0.0%
2015 Q3	61.8 Billion ZAR	-0.51%
2015 Q4	61.8 Billion ZAR	0.0%
2014 Q2	55.16 Billion ZAR	0.0%
2014 Q3	54.3 Billion ZAR	-1.57%
2014 FY	54.25 Billion ZAR	1.09%
2014 Q4	54.25 Billion ZAR	-0.08%
2014 Q1	55.16 Billion ZAR	2.78%
2013 Q1	55.38 Billion ZAR	144.83%
2013 Q3	53.67 Billion ZAR	-3.1%
2013 Q4	53.67 Billion ZAR	0.0%
2013 FY	53.67 Billion ZAR	137.24%
2013 Q2	55.38 Billion ZAR	0.0%
2012 Q3	22.62 Billion ZAR	24.4%
2012 Q4	22.62 Billion ZAR	0.0%
2012 FY	22.62 Billion ZAR	57.98%
2012 Q1	18.18 Billion ZAR	27.0%
2012 Q2	18.18 Billion ZAR	0.0%
2011 FY	14.32 Billion ZAR	6.0%
2011 Q4	14.32 Billion ZAR	300.0%
2011 Q3	3.58 Billion ZAR	-74.38%
2011 Q2	13.97 Billion ZAR	313.73%
2011 Q1	3.37 Billion ZAR	-75.0%
2010 Q2	9.38 Billion ZAR	320.91%
2010 FY	13.51 Billion ZAR	51.55%
2010 Q3	3.37 Billion ZAR	-64.0%
2010 Q4	13.51 Billion ZAR	300.0%
2010 Q1	2.22 Billion ZAR	-75.0%
2009 Q3	2.22 Billion ZAR	-73.48%
2009 FY	8.91 Billion ZAR	7.94%
2009 Q4	8.91 Billion ZAR	300.0%
2009 Q1	2.06 Billion ZAR	-75.0%
2009 Q2	8.4 Billion ZAR	307.03%
2008 Q3	2.06 Billion ZAR	9.68%
2008 FY	8.25 Billion ZAR	9.68%
2008 Q1	1.88 Billion ZAR	0.0%
2008 Q2	1.88 Billion ZAR	0.0%
2008 Q4	8.25 Billion ZAR	300.0%
2007 Q4	1.88 Billion ZAR	0.0%
2007 Q3	1.88 Billion ZAR	46.42%
2007 Q2	1.28 Billion ZAR	0.0%
2007 Q1	1.28 Billion ZAR	0.0%
2007 FY	7.52 Billion ZAR	46.42%
2006 Q4	1.28 Billion ZAR	0.0%
2006 Q1	635.91 Million ZAR	0.0%
2006 Q2	635.91 Million ZAR	0.0%
2006 FY	5.14 Billion ZAR	102.17%
2006 Q3	1.28 Billion ZAR	102.17%
2005 Q2	507.38 Million ZAR	0.0%
2005 Q1	507.38 Million ZAR	0.0%
2005 FY	2.54 Billion ZAR	25.33%
2005 Q4	635.91 Million ZAR	0.0%
2005 Q3	635.91 Million ZAR	25.33%
2004 FY	2.02 Billion ZAR	94.55%
2004 Q1	260.79 Million ZAR	0.0%
2004 Q2	260.79 Million ZAR	0.0%
2004 Q3	507.38 Million ZAR	94.55%
2004 Q4	507.38 Million ZAR	0.0%
2003 FY	1.04 Billion ZAR	17.64%
2003 Q1	221.68 Million ZAR	0.0%
2003 Q3	260.79 Million ZAR	17.64%
2003 Q2	221.68 Million ZAR	0.0%
2003 Q4	260.79 Million ZAR	0.0%
2002 Q3	221.68 Million ZAR	0.0%
2002 Q4	221.68 Million ZAR	0.0%
2002 FY	886.73 Million ZAR	0.0%

Peer Total Liabilities Comparison of Aspen Pharmacare Holdings Limited

Name	Total Liabilities	Total Liabilities Difference

Global Stocks Search

Aspen Pharmacare Holdings Limited (APN.JO)

Total Liabilities Summary of Aspen Pharmacare Holdings Limited

Annual Total Liabilities Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Total Liabilities of Aspen Pharmacare Holdings Limited (2023 - 2002)

Peer Total Liabilities Comparison of Aspen Pharmacare Holdings Limited